Merck & Co Inc (NYSE:MRK)

Delayed Data
As of Mar 19
 -1.04 / -1.87%
Today’s Change
Today|||52-Week Range
Health Technology
Pharmaceuticals: Major

Company Description

Merck & Co., Inc. engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, Alliances and Healthcare Services. The Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the company or through joint ventures. Its human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. The Animal Health segment discovers, develops, manufactures and markets animal health products, including vaccines, which it sells to veterinarians, distributors and animal producers. The Alliances segment includes revenue from the company relationship with AstraZeneca LP. The Healthcare Services segment provides services and solutions that focus on engagement, health analytics and clinical services to improve the value of care delivered to patients. The company was founded in 1970 and is headquartered in Kenilworth, NJ.

Contact Information

Merck & Co., Inc.
2000 Galloping Hill Road
Kenilworth New Jersey 07033
P:(908) 740-4000
Investor Relations:
(908) 740-1986



Mutual fund holders40.13%
Other institutional35.19%
Individual stakeholders0.10%

Top Executives

Kenneth C. FrazierChairman, President & Chief Executive Officer
Robert M. DavisCFO & Executive Vice President-Global Services
Clark GolestaniChief Information Officer & Executive VP
Roy D. BaynesChief Medical Officer
Adam H. SchechterExecutive VP & President-Global Human Health